Cardiology

ISPOR 2026: Top Cardiology Innovations & Research Highlights

ISPOR 2026 cardiology sessions emphasized the critical role of health economics, real-world evidence, and digital health technologies in shaping cardiovascular drug development and clinical adoption strategies.

ISPOR 2026: Cardiology Advances in Cost-Effectiveness Research

ISPOR 2026 highlighted emerging cost-effectiveness frameworks for cardiovascular interventions and emphasized the critical role of real-world evidence in supporting value-based cardiology care and reimbursement decisions.

ISPOR 2026: Cardiology Advances - Day 1 Roundup

NovaPharmaNews is monitoring ISPOR 2026 for cardiology and health economics content, but cannot publish Day 1 coverage without verified data, official abstracts, and named sources. We remain committed to accurate, fact-based reporting.

ISPOR 2026: Cardiology Highlights - Day 1 Roundup

Day 1 of ISPOR 2026 featured discussions on the economic implications of novel therapies in cardiology and the need for comprehensive cost-effectiveness analyses. Emerging trends suggest a growing interest in personalized medicine approaches to cardiovascular care.

ISPOR 2026: HEOR Trends in Cardiology - What to Expect

A preview of cardiology-related health economics and outcomes research (HEOR) to be presented at ISPOR 2026, including ATTR-CM research and real-world evidence applications.